Mirum Pharmaceuticals (MIRM) Interest & Investment Income (2019 - 2026)

Mirum Pharmaceuticals' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 12.5% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $13.1 million (down 0.58% YoY), while the FY2025 annual figure was $12.7 million, down 7.72% from the prior year.
• Interest & Investment Income was $3.4 million for Q1 2026 at Mirum Pharmaceuticals, down from $3.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $4.1 million in Q3 2023 to a low of $69000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $2.8 million across 5 years, with a median of $3.3 million in 2025.
• Biggest YoY gain for Interest & Investment Income was 3196.92% in 2022; the steepest drop was 53.69% in 2022.
• A 5-year view of Interest & Investment Income shows it stood at $2.1 million in 2022, then soared by 76.15% to $3.8 million in 2023, then slipped by 15.13% to $3.2 million in 2024, then gained by 6.74% to $3.4 million in 2025, then fell by 0.56% to $3.4 million in 2026.
• The last three Interest & Investment Income figures came in at $3.4 million (Q1 2026), $3.4 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.